Laboratory IGBMC (Institute of Genetics and of Molecular and Cellular Biology), Centre for Integrative Biology (CBI), Illkirch, France.
Université de Strasbourg (Unistra), Strasbourg, France.
Front Endocrinol (Lausanne). 2023 Jun 19;14:1197063. doi: 10.3389/fendo.2023.1197063. eCollection 2023.
Hepatocyte Nuclear Factor 4 (HNF4) is a transcription factor (TF) belonging to the nuclear receptor (NR) family that is expressed in liver, kidney, intestine and pancreas. It is a master regulator of liver-specific gene expression, in particular those genes involved in lipid transport and glucose metabolism and is crucial for the cellular differentiation during development. Dysregulation of HNF4 is linked to human diseases, such as type I diabetes (MODY1) and hemophilia. Here, we review the structures of the isolated HNF4 DNA binding domain (DBD) and ligand binding domain (LBD) and that of the multidomain receptor and compare them with the structures of other NRs. We will further discuss the biology of the HNF4α receptors from a structural perspective, in particular the effect of pathological mutations and of functionally critical post-translational modifications on the structure-function of the receptor.
肝细胞核因子 4(HNF4)是一种转录因子(TF),属于核受体(NR)家族,在肝脏、肾脏、肠道和胰腺中表达。它是肝脏特异性基因表达的主要调节因子,特别是那些参与脂质转运和葡萄糖代谢的基因,对于发育过程中的细胞分化至关重要。HNF4 的失调与人类疾病有关,如 1 型糖尿病(MODY1)和血友病。在这里,我们回顾了分离的 HNF4 DNA 结合域(DBD)和配体结合域(LBD)以及多结构域受体的结构,并将其与其他 NR 的结构进行了比较。我们将进一步从结构的角度讨论 HNF4α 受体的生物学,特别是病理性突变和功能关键的翻译后修饰对受体结构-功能的影响。